Outset Medical Q3 revenue rises as net loss narrows
OM•Outset Medical’s third-quarter revenue rose 14% year over year to $33.6 million, while its net loss narrowed to $14.7 million from $17.8 million. The company reiterated 2026 revenue guidance of $125 million to $130 million.
1. Quarterly results
Third-quarter revenue increased 14% year over year to $33.6 million. Gross margin expanded to 40.7% from 39.4%, and net loss narrowed to $14.7 million from $17.8 million a year earlier.
2. Revenue and outlook
Outset said higher console revenue and growth in Tablo consumables and services supported quarterly revenue. It reiterated its 2026 revenue guidance of $125 million to $130 million and expects 2026 non-GAAP gross margin in the low-40% to mid-40% range.
